Menu Search
Equities

China Resources Medical Holdings Company Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert
1PH:FRA

China Resources Medical Holdings Company Ltd

Actions
  • Price (EUR)0.33
  • Today's Change-0.002 / -0.60%
  • Shares traded100.00
  • 1 Year change-31.25%
  • Beta1.0176
Data delayed at least 15 minutes, as of Feb 16 2026 07:03 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

China Resources Medical Holdings Company Ltd, formerly China Resources Phoenix Healthcare Holdings Company Ltd, is a China-based holding company mainly engaged in hospital business. The Company is engaged in providing comprehensive medical services, providing hospital management services, and selling medicines, medical devices and medical consumables, as well as providing other hospital derivative services to related hospitals. The Company operates in two segments. Hospital Business segment includes outpatient and inpatient services corresponding to its own hospitals. Other Business segment includes operation management services, supply chain services and other derivative services provided to joint-stock hospitals and IOT/OT hospitals. The Company mainly operates in the domestic market.

  • Revenue in HKD (TTM)10.65bn
  • Net income in HKD533.96m
  • Incorporated2013
  • Employees19.74k
  • Location
    China Resources Medical Holdings Company LtdE-825No. 6 Taiping Street, Xicheng DistrictBEIJING 100050ChinaCHN
  • Phone+86 1 059361058
  • Fax+86 1 059361935
  • Websitehttp://www.crmedical.hk/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.